While these medications are most effective when combined with lifestyle interventions, inability to successfully engage in these interventions should not necessarily be a reason to withhold therapy given the significant consequences of obesity
Based on analysis of employer experiences, vendor data, and expert interviews, PHTI outlines five key recommendations for employers: Establish clear, clinically driven eligibility pathways for GLP-1 coverage Require participation in behavior, nutrition, or lifestyle change programs as a condition of coverage Provide structured support for employees who choose to taper or discontinue GLP-1 therapy Review existing vendor capabilities before adding additional point solutions Contract with vendors to drive outcomes while examining overall program costs The report identifies three critical phases where these solutions can support employers in managing their GLP-1 coverage: Initiation: Providing targeted GLP-1 coverage using clinical criteria, behavioral or AI-based screening, narrow prescribing networks, or step-therapy pathways that include lower-cost alternatives or lifestyle change programs
1 Synthesis of silver nanoparticles is of much interest to the scientific community because of their wide range of applications in catalysis, 2 electronics, 3 photonics, 4 optoelectronics, 5 sensing, 6 and pharmaceuticals
Lheureux PE, Hantson P: Carnitine in the treatment of valproic acid-induced toxicity
Poor Diet : Diets low in nutrient-dense foods and high in processed foods can negatively impact glutathione levels
At $134$300, the price tags make me seriously pause
